Wenxia Si

458 total citations
15 papers, 326 citations indexed

About

Wenxia Si is a scholar working on Molecular Biology, Cancer Research and Oncology. According to data from OpenAlex, Wenxia Si has authored 15 papers receiving a total of 326 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Molecular Biology, 7 papers in Cancer Research and 4 papers in Oncology. Recurrent topics in Wenxia Si's work include Cancer, Hypoxia, and Metabolism (3 papers), MicroRNA in disease regulation (3 papers) and Histone Deacetylase Inhibitors Research (2 papers). Wenxia Si is often cited by papers focused on Cancer, Hypoxia, and Metabolism (3 papers), MicroRNA in disease regulation (3 papers) and Histone Deacetylase Inhibitors Research (2 papers). Wenxia Si collaborates with scholars based in China and United States. Wenxia Si's co-authors include Bisheng Zhou, Xu Yan, Qing Wang, Sisi Li, Ruihua Ma, Xin Tu, Zhenhong Su, Qing K. Wang, Chengqi Xu and Xin Tu and has published in prestigious journals such as PLoS ONE, The FASEB Journal and FEBS Letters.

In The Last Decade

Wenxia Si

13 papers receiving 324 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Wenxia Si China 7 229 175 41 31 25 15 326
Yvan de Féraudy France 3 326 1.4× 277 1.6× 44 1.1× 21 0.7× 29 1.2× 6 434
Lalita Uttarwar Canada 7 211 0.9× 134 0.8× 31 0.8× 30 1.0× 38 1.5× 7 351
Michael O. Idowu United States 6 151 0.7× 81 0.5× 48 1.2× 30 1.0× 31 1.2× 8 295
Ping Tong China 10 213 0.9× 173 1.0× 18 0.4× 26 0.8× 23 0.9× 17 417
Qingchuan Dong China 7 212 0.9× 185 1.1× 31 0.8× 38 1.2× 20 0.8× 11 344
Matthew S. Yan Canada 7 296 1.3× 206 1.2× 20 0.5× 37 1.2× 30 1.2× 8 412
Hongjun Zhu China 10 176 0.8× 106 0.6× 74 1.8× 24 0.8× 47 1.9× 16 294
Huyan Chen China 6 269 1.2× 241 1.4× 33 0.8× 17 0.5× 25 1.0× 12 379
Tania Tsatralis Australia 10 191 0.8× 79 0.5× 40 1.0× 30 1.0× 37 1.5× 11 335
Rongjian Xu China 8 148 0.6× 123 0.7× 23 0.6× 24 0.8× 17 0.7× 32 261

Countries citing papers authored by Wenxia Si

Since Specialization
Citations

This map shows the geographic impact of Wenxia Si's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Wenxia Si with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Wenxia Si more than expected).

Fields of papers citing papers by Wenxia Si

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Wenxia Si. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Wenxia Si. The network helps show where Wenxia Si may publish in the future.

Co-authorship network of co-authors of Wenxia Si

This figure shows the co-authorship network connecting the top 25 collaborators of Wenxia Si. A scholar is included among the top collaborators of Wenxia Si based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Wenxia Si. Wenxia Si is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

15 of 15 papers shown
1.
Huang, Mi Ni, Duanzhuo Li, Shengjie Liao, et al.. (2025). Silencing NRF2 enhances arsenic trioxide-induced ferroptosis in hepatocellular carcinoma cells. PLoS ONE. 20(5). e0322746–e0322746. 1 indexed citations
2.
3.
Yuan, Chao, Wenxia Si, Mi Huang, et al.. (2024). Trim21 modulates endoplasmic reticulum-associated degradation and sensitizes cancer cells to ER stress-induced apoptosis by inhibiting VCP/Npl4/UFD1 assembly. Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease. 1871(1). 167533–167533. 2 indexed citations
4.
Yuan, Chao, Shengjie Liao, Mi Huang, et al.. (2023). Triptolide inhibits the progression of Glioblastoma U251 cells via targeting PROX1. Frontiers in Oncology. 13. 1077640–1077640. 5 indexed citations
5.
Yuan, Chao, Mi Huang, Wenxia Si, et al.. (2023). AZD7762 induces CRBN dependent BAG3 degradation through ubiquitin-proteasome pathway. Anti-Cancer Drugs. 35(1). 46–54. 2 indexed citations
6.
Yuan, Chao, Zhenhong Su, Shengjie Liao, et al.. (2021). miR-198 inhibits the progression of renal cell carcinoma by targeting BIRC5. Cancer Cell International. 21(1). 390–390. 8 indexed citations
7.
Su, Zhenhong, et al.. (2021). [Network pharmacology-based study of the therapeutic mechanism of resveratrol for Alzheimer's disease].. PubMed. 41(1). 10–19. 5 indexed citations
8.
Huang, Yuan, et al.. (2020). Elevated MTA1 induced the migration and invasion of renal cell carcinoma through the NF-κB pathway. BMC Urology. 20(1). 160–160. 5 indexed citations
9.
Si, Wenxia, Bisheng Zhou, Hui Li, et al.. (2020). Angiogenic factor AGGF1 acts as a tumor suppressor by modulating p53 post-transcriptional modifications and stability via MDM2. Cancer Letters. 497. 28–40. 18 indexed citations
10.
Chen, Cheng, Huixia Liu, Chengcheng Tan, et al.. (2019). Mutation in NPPA causes atrial fibrillation by activating inflammation and cardiac fibrosis in a knock‐in rat model. The FASEB Journal. 33(8). 8878–8891. 22 indexed citations
11.
Si, Wenxia, et al.. (2018). Abstract 501: Angiotensin II Increases Angiogenesis by Nf-κB-mediated Transcriptional Activation of Angiogenic Factor Aggf1. Arteriosclerosis Thrombosis and Vascular Biology. 38(Suppl_1).
12.
Si, Wenxia, Yi Xiao, Sadashiva S. Karnik, et al.. (2018). Angiotensin II increases angiogenesis by NF‐κB–mediated transcriptional activation of angiogenic factor AGGF1. The FASEB Journal. 32(9). 5051–5062. 23 indexed citations
13.
Su, Zhenhong, Wenxia Si, Lei Li, et al.. (2014). MiR-144 regulates hematopoiesis and vascular development by targeting meis1 during zebrafish development. The International Journal of Biochemistry & Cell Biology. 49. 53–63. 38 indexed citations
14.
Zhou, Bisheng, Ruihua Ma, Wenxia Si, et al.. (2013). MicroRNA-503 targets FGF2 and VEGFA and inhibits tumor angiogenesis and growth. Cancer Letters. 333(2). 159–169. 161 indexed citations
15.
Zhou, Bisheng, Wenxia Si, Zhenhong Su, et al.. (2013). Transcriptional activation of the Prox1 gene by HIF‐1α and HIF‐2α in response to hypoxia. FEBS Letters. 587(6). 724–731. 36 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Yvan de Féraudy Breakdown of academic impact, for papers by Lalita Uttarwar Breakdown of academic impact, for papers by Michael O. Idowu Breakdown of academic impact, for papers by Ping Tong Breakdown of academic impact, for papers by Qingchuan Dong Breakdown of academic impact, for papers by Matthew S. Yan Breakdown of academic impact, for papers by Hongjun Zhu Breakdown of academic impact, for papers by Huyan Chen Breakdown of academic impact, for papers by Tania Tsatralis Breakdown of academic impact, for papers by Rongjian Xu
Rankless by CCL
2026